{"organizations": ["Morgan Stanley Global Healthcare Conference", "Medical Devices Directive Seminar", "Valeant Pharmaceuticals International, Inc.", "Elekta", "Says New Analysis of Women's Health Initiative Data Liraglutide", "Morgan Stanley Global   Valeant Pharmaceuticals To Acquire Synergetics USA", "Host Cancer Survivorship Event at Company", "LINC", "Leksell Gamma Knife"], "uuid": "6269d66605285423bedb524b82846d94ccca9f0a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/An-Introduction-to-the-Medical-Devices-Directive-Seminar---London--UK---November-10-12--2015-47946-1/", "country": "US", "title": "An Introduction to the Medical Devices Directive Seminar - London, UK - November 10-12, 2015", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "An Introduction to the Medical Devices Directive Seminar - London, UK - November 10-12, 2015", "spam_score": 0.0, "site_type": "news", "published": "2015-09-02T20:51:00.000+03:00", "replies_count": 0, "uuid": "6269d66605285423bedb524b82846d94ccca9f0a"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/An-Introduction-to-the-Medical-Devices-Directive-Seminar---London--UK---November-10-12--2015-47946-1/", "ord_in_thread": 0, "title": "An Introduction to the Medical Devices Directive Seminar - London, UK - November 10-12, 2015", "locations": ["Mass.", "Atlanta", "Boston", "UK", "London"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Dan", "Mike Mahoney"], "text": "  , September 2, 2015 Elekta, ... on cancer survivorship on September 10, 6:30-8:30 p.m., at Elekta,s ... Elekta,s Ultimate Ride to Survivorship \" will feature Professional BMX ... treatment of a brain tumor with Leksell Gamma KnifeÂ®, Elekta,s ... 48,070 new cancer cases will be diagnosed in   Mass. , Sept. 2, 2015 Boston Scientific ... the 2015 Morgan Stanley Global Healthcare Conference on September 17, ... Mike Mahoney , chief executive officer, and Dan ... participate in a 30-minute question and answer session regarding the ... ET. A live webcast of the question and   2015 Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... has entered into a definitive agreement under which Valeant ... (NASDAQ: SURG ) for $6.50 per share in ... stockholders will receive additional cash payments of up to ... following the closing. The transaction is expected to close ... [ 0 ] Elekta to Host Cancer Survivorship Event at Company's Learning and Innovation Center (LINC) in Atlanta [ 0 ] Boston Scientific To Participate In 2015 Morgan Stanley Global   Valeant Pharmaceuticals To Acquire Synergetics USA ... Fourth Study to Indicate that Early Use of ... -- A new analysis,of Women's Health Initiative data ... significant reduction in calcified,plaque for women aged 50 ... taking a placebo. This is the first time ... ... 2007-Novo Nordisk today announced clinical,results from the first ... once-daily human GLP-1 analogue. The 26-week study is ... Diabetes) programme,and included 581 patients with type 2 ... used oral antidiabetic drugs:,metformin and a sulfonylurea (glimepiride). ... Arterial Plaque Significantly Reduced in Women Age 50-59 Taking,Hormones, Says New Analysis of Women's Health Initiative Data Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study  ", "external_links": [], "published": "2015-09-02T20:51:00.000+03:00", "crawled": "2015-09-03T03:07:22.354+03:00", "highlightTitle": ""}